Former B Capital Group partners have formed a $100m venture fund that will principally target Southeast Asia-based technology startups.

Trustbridge Partners has acquired a majority stake in WeWork China, a SoftBank-backed company that was at one point valued at $5bn.

Xingyun has picked up $200m in a series C round co-led by Taikang Insurance, Shanghai United Media Group and Highlight Capital, while GLP and C&D Group also invested.

Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Formerly known as Aihuishou, the electronics recycler has attracted more than $100m in series E-plus funding co-led by existing shareholder JD.com.

Nucarf has procured approximately $100m in combined series A and A-plus funding, with the former round featuring Xiamen C&D.

Green Monday is working on a plant-based alternative to pork and has raised the money from investors including Swire Pacific and returning backer Lee Kum Kee Health Products.

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.